Sniffing for immunity: new nasal spray COVID vaccine enters human testing
NCT ID NCT07215520
Summary
This study is testing a new COVID-19 booster vaccine given as a nasal spray. It will compare the spray's safety and the immune response it creates to a standard mRNA vaccine shot. The trial will enroll about 200 adults who have already been vaccinated against COVID-19 at least 6 months ago.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Skylight Health Research
RECRUITINGColorado Springs, Colorado, 80917, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Skylight Health Research
RECRUITINGBurlington, Massachusetts, 01803, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.